BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 71.46 Million | 31.14 Million | 2.13 Million | 17.94 Million | 10 Million |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | 71.46 Million | 31.14 Million | 2.13 Million | 17.94 Million | 10 Million |
| Operating Expenses | 441.4 Million | 34.56 Million | 31.17 Million | 25.76 Million | 24.76 Million |
| Selling, General and Administrative Expenses | 51.6 Million | 4.76 Million | 4.27 Million | 3.85 Million | 3.1 Million |
| Research and Development Expenses | 390.43 Million | 29.8 Million | 26.9 Million | 21.9 Million | 22.19 Million |
| Other Expenses | -637 Thousand | - | - | - | - |
| Cost and Expenses | 441.4 Million | 35.97 Million | 32.78 Million | 27.22 Million | 24.76 Million |
| Operating Income | -369.94 Million | -4.82 Million | -30.65 Million | -9.27 Million | -14.62 Million |
| Interest Expense | 638 Thousand | 62.07 Thousand | 56.92 Thousand | 40.91 Thousand | 51.48 Thousand |
| Income Tax Expense | 204 Thousand | -866.37 Thousand | -29.06 Thousand | -3409.42 | -6943.67 |
| Earnings before Tax | -330.1 Million | -4.05 Million | -30.65 Million | -9.29 Million | -14.8 Million |
| Net Income | -330.3 Million | -4.05 Million | -30.65 Million | -9.29 Million | -14.8 Million |
| Earnings Per Share Basic | -5.02 | -0.07 | -0.57 | -0.32 | -0.82 |
| Earnings Per Share Diluted | -5.02 | -0.07 | -0.57 | -0.32 | -0.82 |
| Weighted Average Shares Outstanding | 65.79 Million | 61.52 Million | 54.16 Million | 28.71 Million | 18.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.79 Million | 61.52 Million | 54.16 Million | 28.71 Million | 18.14 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -4.38 | -0.11 | -13.61 | -0.44 | -1.40 |
| Profit Margin | -4.62 | -0.13 | -14.36 | -0.52 | -1.48 |
| EBITDA | -312.7 Million | -27.12 Million | -29.04 Million | -7.79 Million | -14.01 Million |
| Earnings Before Tax Margin | -5.18 | -0.16 | -14.36 | -0.52 | -1.46 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.25 Million | 4.61 Million | 554.98 Thousand | 7.05 Million | 1.51 Million | 2.44 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 1.25 Million | 4.61 Million | 554.98 Thousand | 7.05 Million | 1.51 Million | 2.44 Million |
| Operating Expenses | 11.31 Million | 152.93 Million | 8.49 Million | 41.97 Million | 12.05 Million | 9.46 Million |
| Selling, General and Administrative Expenses | 782.72 Thousand | 14.47 Million | 802.58 Thousand | - | 1.04 Million | 641.59 Thousand |
| Research and Development Expenses | 10.53 Million | 138.59 Million | 7.69 Million | - | 11.01 Million | 8.82 Million |
| Other Expenses | - | -13.3 Thousand | - | - | - | - |
| Cost and Expenses | 11.78 Million | 152.93 Million | 8.93 Million | 43.62 Million | 12.5 Million | 9.84 Million |
| Operating Income | -10.53 Million | -148.32 Million | -8.38 Million | -36.57 Million | -10.99 Million | -7.4 Million |
| Interest Expense | - | - | - | 638 Thousand | - | - |
| Income Tax Expense | 2744.00 | 28 Thousand | 2895.40 | 20.13 Thousand | 20.13 Thousand | -934.98 Thousand |
| Earnings before Tax | -9.52 Million | -137.27 Million | -7.27 Million | -32.58 Million | -9.56 Million | -6.48 Million |
| Net Income | -9.52 Million | -137.3 Million | -7.28 Million | -32.6 Million | -9.58 Million | -6.48 Million |
| Earnings Per Share Basic | -0.14 | -2.09 | -0.11 | - | -0.15 | -0.10 |
| Earnings Per Share Diluted | -0.14 | -2.09 | -0.11 | - | -0.15 | -0.10 |
| Weighted Average Shares Outstanding | 65.8 Million | 65.8 Million | 65.8 Million | 65.76 Million | 65.8 Million | 65.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.8 Million | 65.8 Million | 65.8 Million | 65.76 Million | 65.8 Million | 65.8 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -7.24 | -33.50 | -14.31 | - | -6.98 | -2.87 |
| Profit Margin | -7.62 | -29.78 | -13.12 | -4.62 | -6.34 | -2.65 |
| EBITDA | -9.05 Million | -154.48 Million | -7.94 Million | - | -10.54 Million | -7.01 Million |
| Earnings Before Tax Margin | -8.42 | -32.17 | -15.10 | -5.19 | -7.27 | -3.03 |
AV-B
SHILPAMED
VFRM
9511
IDIA
AL-PA